Triptolide attenuates cardiac remodeling by inhibiting pyroptosis and EndMT via modulating USP14/Keap1/Nrf2 pathway
Background: Cardiac remodeling is a common pathological feature in many cardiac diseases, characterized by cardiac hypertrophy and fibrosis. Triptolide (TP) is a natural compound derived from Tripterygium wilfordii Hook F. However, the related mechanism of it in cardiac remodeling has not been fully...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2024-01-01
|
| シリーズ: | Heliyon |
| 主題: | |
| オンライン・アクセス: | http://www.sciencedirect.com/science/article/pii/S2405844024000410 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
